Literature DB >> 537013

Genetic control of severe pre-eclampsia.

D W Cooper, W A Liston.   

Abstract

A genetic analysis has been made of published and new data on the familial occurrence of severe pre-eclampsia in primigravid women. This has shown that the condition may be largely a Mendelian recessive one. Bcause the condition occurs only in pregnancy, and because susceptible women cannot otherwise be identified, it is difficult to decide whether the genotype of the parent or of the offspring carried in utero leads to the condition. Data on the incidence of severe pre-eclampsia in the relatives of women who have suffered eclampsia support the maternal genotype hypothesis, while similar data, in which the index cases were women who had had severe pre-eclampsia, are more compatible with the fetal genotype hypothesis. Data on the incidence of the condition in blood relatives of index cases compared to the incidence in their corresponding in-laws are now required. Such a comparison would allow a choice to be made between the two hypotheses if one or the other were correct, or would assess the contribution of each if a genotype X genotype interaction were involved. Recurrent severe pre-eclampsia seems to have the same genetic basis as the more common primigravid type. However, mild, that is non-proteinuric, pre-eclampsia usually seems to be inherited independently of the severe form.

Entities:  

Mesh:

Year:  1979        PMID: 537013      PMCID: PMC1012584          DOI: 10.1136/jmg.16.6.409

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  A clinical study of pre-eclampsia. I.

Authors:  T R NELSON
Journal:  J Obstet Gynaecol Br Emp       Date:  1955-02

2.  Pregnancies in the sisters and daughters of eclamptic women.

Authors:  L C CHESLEY; R A COSGROVE; J E ANNITTO
Journal:  Obstet Gynecol       Date:  1962-07       Impact factor: 7.661

3.  Familial aspects of pre-eclampsia and hypertension in pregnancy.

Authors:  E M ADAMS; A FINLAYSON
Journal:  Lancet       Date:  1961-12-23       Impact factor: 79.321

4.  Long-term effect of preeclampsia on blood-pressure.

Authors:  E M ADAMS; I MACGILLIVRAY
Journal:  Lancet       Date:  1961-12-23       Impact factor: 79.321

5.  Some observations on the incidence of pre-eclampsia.

Authors:  I MACGILLIVRAY
Journal:  J Obstet Gynaecol Br Emp       Date:  1958-08

6.  The aetiology, incidence, and heredity of pre-eclamptic toxaemia of pregnancy.

Authors:  R PLATT; A E STEWART; E W EMERY
Journal:  Lancet       Date:  1958-03-15       Impact factor: 79.321

7.  Androgenetic origin of hydatidiform mole.

Authors:  T Kajii; K Ohama
Journal:  Nature       Date:  1977-08-18       Impact factor: 49.962

8.  Immunology of pre-eclampsia.

Authors:  J S Scott; D M Jenkins; J A Need
Journal:  Lancet       Date:  1978-04-01       Impact factor: 79.321

9.  HLA antigens in severe pre-eclampsia.

Authors:  C W Redman; J G Bodmer; W F Bodmer; L J Beilin; J Bonnar
Journal:  Lancet       Date:  1978-08-19       Impact factor: 79.321

10.  Human leucocyte antigens and mixed lymphocyte reaction in severe pre-eclampsia.

Authors:  D M Jenkins; J A Need; J S Scott; H Morris; M Pepper
Journal:  Br Med J       Date:  1978-03-04
View more
  10 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance.

Authors:  C Hayward; J Livingstone; S Holloway; W A Liston; D J Brock
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

3.  Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region.

Authors:  R Arngrímsson; C Hayward; S Nadaud; A Baldursdóttir; J J Walker; W A Liston; R I Bjarnadóttir; D J Brock; R T Geirsson; J M Connor; F Soubrier
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

4.  A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q.

Authors:  G A Harrison; K E Humphrey; N Jones; R Badenhop; G Guo; G Elakis; J A Kaye; R J Turner; M Grehan; A N Wilton; S P Brennecke; D W Cooper
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

5.  An epidemiological study of the immunogenetic aetiology of pre-eclampsia.

Authors:  B W Alderman; R S Sperling; J R Daling
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-08

6.  Inheriting pre-eclampsia.

Authors: 
Journal:  Br Med J       Date:  1980-06-28

7.  Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor.

Authors:  Lara Carvalho Godoi; Karina Braga Gomes; Patrícia Nessralla Alpoim; Maria das Graças Carvalho; Bashir A Lwaleed; Luci Maria Sant'Ana Dusse
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

8.  A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2.

Authors:  E K Moses; J A Lade; G Guo; A N Wilton; M Grehan; K Freed; A Borg; J D Terwilliger; R North; D W Cooper; S P Brennecke
Journal:  Am J Hum Genet       Date:  2000-10-17       Impact factor: 11.043

9.  Obstetric prognosis in sisters of preeclamptic women - implications for genetic linkage studies.

Authors:  Nonna Heiskanen; Seppo Heinonen; Pertti Kirkinen
Journal:  BMC Womens Health       Date:  2003-02-23       Impact factor: 2.809

10.  The Norwegian preeclampsia family cohort study: a new resource for investigating genetic aspects and heritability of preeclampsia and related phenotypes.

Authors:  Linda Tømmerdal Roten; Liv Cecilie Vestrheim Thomsen; Astrid Solberg Gundersen; Mona Høysæter Fenstad; Maria Lisa Odland; Kristin Melheim Strand; Per Solberg; Christian Tappert; Elisabeth Araya; Gunhild Bærheim; Ingvill Lyslo; Kjersti Tollaksen; Line Bjørge; Rigmor Austgulen
Journal:  BMC Pregnancy Childbirth       Date:  2015-12-01       Impact factor: 3.007

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.